Clinical Trials at Oncology Associates of Oregon, P.C.
As of August 2026, 11 paid clinical trials are recruiting at Oncology Associates of Oregon, P.C., located at 520 COUNTRY CLUB, EUGENE, OR 97401-6036, phone (541) 683-5001 in Eugene, Oregon. Active studies at this site cover conditions such as Endometrial Cancer, Multiple Myeloma and Chronic Lymphocytic Leukemia. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
View the full facility profile →
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
11 clinical trials at Oncology Associates of Oregon, P.C.
·Clear filters·Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)
Symbiotic-Lung-20: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Different Anticancer Agents in Advanced Cancers
Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)
A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.
A Study of Raludotatug Deruxtecan (R-DXd) in Subjects With Platinum-resistant, High-grade Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
A Study of Disitamab Vedotin in Adults With HER2 Expressing Advanced Breast Cancer
Sapanisertib and Serabelisib (PIKTOR) With Paclitaxel and a Substudy With an Insulin-Suppressing Diet in Patients With Advanced/Recurrent Endometrial Cancer
Study on Efficacy and Safety of Givinostat Versus Hydroxyurea in Patients With Polycythemia Vera
Common conditions studied in Eugene
- Endometrial Cancer (8 active studies)
- Multiple Myeloma (6 active studies)
- Chronic Lymphocytic Leukemia (5 active studies)
- Fallopian Tube Cancer (4 active studies)
- Ovarian Cancer (4 active studies)
- Breast Cancer (3 active studies)
Leading research sponsors in Eugene
- University of Oregon
- AbbVie
- Pfizer
- Eli Lilly and Company
- Janssen Research & Development, LLC
Frequently asked questions
How many paid clinical trials are currently recruiting in Eugene?
There are approximately 129 recruiting clinical trials in Eugene, Oregon listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Eugene pay participants?
Most recruiting trials in Eugene compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Eugene?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Eugene?
The most common conditions under active study in Eugene include Endometrial Cancer (8), Multiple Myeloma (6), Chronic Lymphocytic Leukemia (5), Fallopian Tube Cancer (4), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Eugene?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Eugene on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Eugene?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Eugene?
Recruiting research sites in Eugene include Willamette Valley Cancer Institute and Research Center, Oncology Associates of Oregon, P.C., University of Oregon, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Eugene right now?
The largest active categories in Eugene are Cancer & tumors (61), Eye & vision (10), Mental health & behavior (7). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.
What is the address of Oncology Associates of Oregon, P.C.?
Oncology Associates of Oregon, P.C. is located at 520 COUNTRY CLUB, EUGENE, OR 97401-6036. Use the Google Maps link in the intro above to get directions.
How do I contact Oncology Associates of Oregon, P.C.?
You can reach Oncology Associates of Oregon, P.C. by phone at (541) 683-5001. For questions about a specific trial, use the study coordinator contact listed on the individual study record — click any trial title above to open it.